More from Economic Studies
Threats to Medicare’s new drug negotiation power. Richard Frank and Len Nichols argue that language in a new bill and a letter to the Department of Health and Human Services would prohibit certain metrics that the government uses to evaluate the effectiveness of different drugs. This could compromise the ability of both public agencies and private companies to negotiate drug prices on behalf of a large share of the American public.
Capital regulation and the Treasury market. Disruptions of the market for U.S. Treasury debt in September 2019 and March 2020 have raised the issue of whether the treatment of central bank reserves and sovereign debt in bank capital requirements exacerbated the problems. Daniel Tarullo evaluates proposed reforms.
